M&A Deal Summary

Immucor Acquires Gen-Probe Holdings

On March 22, 2013, Immucor acquired medical products company Gen-Probe Holdings

Acquisition Highlights
  • This is Immucor’s 1st transaction in the Medical Products sector.
  • This is Immucor’s 2nd transaction in the United States.
  • This is Immucor’s 1st transaction in Connecticut.

M&A Deal Summary
Date 2013-03-22
Target Gen-Probe Holdings
Sector Medical Products
Buyer(s) Immucor
Deal Type Add-on Acquisition

Target

Gen-Probe Holdings

Stamford, Connecticut, United States
Gen-Probe Holdings, Inc. is a manufacturer, and seller of reagents and automated systems used primarily by hospitals, clinical labs.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Immucor

Norcross, Georgia, United States
Category Company
Sector Medical Products
DESCRIPTION

Immucor, Inc. manufactures and sells a complete line of reagents and systems used by hospitals, reference laboratories, and donor centers to detect and identify certain properties of the cell and serum components of blood prior to transfusion. Immucor is based in Norcross, Georgia.

DEAL STATS #
Overall 2 of 5
Sector (Medical Products) 1 of 2
Type (Add-on Acquisition) 1 of 4
State (Connecticut) 1 of 1
Country (United States) 2 of 5
Year (2013) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-01-03 Hologic - LIFECODES business

United States

Hologic - LIFECODES business includes transplantation diagnostics. LIFECODES sells molecular and antibody-based assays in the markets of transplant diagnostics, specialty coagulation and transfusion medicine.

Buy $85M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-06-02 Organ-i

Palo Alto, California, United States

Organ-i, Inc. is a developer of non-invasive tests to monitor and predict organ health for transplant recipients.

Buy -
Mergr

Product

Company

Legal